News

The leading topic of our meeting - the possibilities of medical care in wartime conditions. The following issues will be considered: Combat injury, Chemical attack, Contusion and post-contusion syndrome, Alarm conditions, Acute stroke.

Almost 8 000 health care specialists have registered to participate in the Teleconference "III Interdisciplinary Collegium of Neurological Diseases ", February 23, 2022, Kyiv, Ukraine.

All videos of reports from the online-teleconference "Combat Trauma. Exchange of experience: Ukraine-Israel" which was held on March 13, 2022 are available for viewing on the official YouTube-channel of the Congress on Infusion Therapy. 

All videos of reports from the online-teleconference "III Interdisciplinary Collegium of Neurological Diseases" which was held on February 23, 2022 are available for viewing on the official YouTube-channel of the Congress on Infusion Therapy.

The teleconference will take place on Sunday, March 13. Start at 13:00. It is relevant for all doctors, regardless of specialization, who provide medical care in wartime.

Almost 9 000 health care specialists have registered to participate in the Teleconference “Respiratory diseases should be treated locally. Diagnose as a doctor, treat as a master”, February 10, 2022, Kyiv, Ukraine.

All videos of reports from the online-teleconference "Respiratory diseases - treat respiratory. Diagnose as a doctor, treat as an artist!"which was held on February 10, 2022 are available for viewing on the official YouTube-channel of the Congress on Infusion Therapy.

Dear colleagues, we invite you to attend an event dedicated to the topical issue of medicine - the management of acute cerebral stroke.

All videos of reports from the online-teleconference "Omicron": new challenges and new treatment options" which was held on February 2, 2022 are available for viewing on the official YouTube-channel of the Congress on Infusion Therapy.

Almost 12 000 health care specialists have registered to participate in the Teleconference "Omicron: new challenges, new treatment opportunities", February 2, 2022, Kyiv, Ukraine.